GC
RGEN icon

Guggenheim Capital’s Repligen RGEN Stock Holding History

Guggenheim Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Buy
1,946
+382
+24% +$53.4K ﹤0.01% 1480
2025
Q4 		$256K Buy
+1,564
New +$245K ﹤0.01% 1598
2025
Q1 		– Sell
-1,575
Closed -$227K – 1687
2024
Q4 		$227K Sell
1,575
-111
-7% -$15.9K ﹤0.01% 1552
2024
Q3 		$251K Sell
1,686
-245
-13% -$35.1K ﹤0.01% 1681
2024
Q2 		$243K Sell
1,931
-1,000
-34% -$157K ﹤0.01% 1711
2024
Q1 		$539K Buy
2,931
+542
+23% +$103K ﹤0.01% 1445
2023
Q4 		$430K Sell
2,389
-2,170
-48% -$338K ﹤0.01% 1517
2023
Q3 		$725K Buy
4,559
+382
+9% +$62.4K 0.01% 1248
2023
Q2 		$591K Buy
4,177
+218
+6% +$35K ﹤0.01% 1397
2023
Q1 		$667K Sell
3,959
-2,295
-37% -$409K 0.01% 1366
2022
Q4 		$1.06M Buy
6,254
+1,785
+40% +$324K 0.01% 1131
2022
Q3 		$837K Sell
4,469
-431
-9% -$90.9K 0.01% 1226
2022
Q2 		$796K Sell
4,900
-405
-8% -$64.1K 0.01% 1335
2022
Q1 		$998K Sell
5,305
-2,973
-36% -$565K 0.01% 1361
2021
Q4 		$2.19M Sell
8,278
-2,818
-25% -$759K 0.01% 1010
2021
Q3 		$3.21M Buy
11,096
+74
+0.7% +$19K 0.02% 837
2021
Q2 		$2.2M Sell
11,022
-2,020
-15% -$392K 0.01% 1043
2021
Q1 		$2.54M Sell
13,042
-1,686
-11% -$346K 0.02% 910
2020
Q4 		$2.82M Sell
14,728
-3,227
-18% -$587K 0.02% 819
2020
Q3 		$2.65M Buy
17,955
+4,055
+29% +$580K 0.02% 775
2020
Q2 		$1.72M Buy
13,900
+545
+4% +$64.1K 0.01% 946
2020
Q1 		$1.29M Sell
13,355
-4,007
-23% -$387K 0.01% 983
2019
Q4 		$1.61M Buy
17,362
+4,564
+36% +$383K 0.01% 1132
2019
Q3 		$982K Buy
12,798
+4,979
+64% +$435K 0.01% 1345
2019
Q2 		$672K Buy
7,819
+648
+9% +$44.2K 0.01% 1528
2019
Q1 		$424K Sell
7,171
-1,096
-13% -$63K ﹤0.01% 1763
2018
Q4 		$436K Sell
8,267
-7,464
-47% -$438K ﹤0.01% 1739
2018
Q3 		$872K Buy
15,731
+2,210
+16% +$114K 0.01% 1679
2018
Q2 		$636K Sell
13,521
-33,032
-71% -$1.36M ﹤0.01% 1819
2018
Q1 		$1.69M Buy
46,553
+2,635
+6% +$92.7K ﹤0.01% 1768
2017
Q4 		$1.59M Buy
+43,918
New +$1.59M ﹤0.01% 1825
2016
Q4 		– Sell
-56,847
Closed -$1.72M – 2961
2016
Q3 		$1.72M Sell
56,847
-8,062
-12% -$243K 0.01% 1720
2016
Q2 		$1.78M Sell
64,909
-79,188
-55% -$2.02M 0.01% 1639
2016
Q1 		$3.87M Sell
144,097
-88,461
-38% -$2.16M 0.01% 1133
2015
Q4 		$6.58M Sell
232,558
-34,834
-13% -$1M 0.02% 911
2015
Q3 		$7.45M Sell
267,392
-182
-0.1% -$6.58K 0.02% 868
2015
Q2 		$11M Buy
267,574
+34,189
+15% +$1.25M 0.03% 793
2015
Q1 		$7.09M Buy
233,385
+25,334
+12% +$657K 0.02% 1007
2014
Q4 		$4.12M Sell
208,051
-42,213
-17% -$944K 0.01% 1225
2014
Q3 		$4.98M Buy
250,264
+23,757
+10% +$500K 0.01% 1196
2014
Q2 		$5.16M Buy
226,507
+208,170
+1,135% +$3.71M 0.01% 1167
2014
Q1 		$236K Buy
18,337
+3,076
+20% +$44.1K ﹤0.01% 2832
2013
Q4 		$208K Buy
15,261
+1,294
+9% +$15.4K ﹤0.01% 2822
2013
Q3 		$155K Sell
13,967
-469
-3% -$4.67K ﹤0.01% 2773
2013
Q2 		$119K Buy
+14,436
New +$121K ﹤0.01% 2809

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Guggenheim Capital's RGEN Position: Q1 2026 in Review

Guggenheim Capital increased its Repligen (RGEN) stake by 24% in Q1 2026, buying an estimated $53.4K and bringing the position to 1,946 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

Guggenheim Capital first reported a position in RGEN in Q2 2013 and has held it in 45 quarters since. The position peaked at $11M in Q2 2015. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Guggenheim Capital held 1,946 shares of Repligen worth $229K as of Q1 2026.
  • Guggenheim Capital bought 382 Repligen shares in Q1 2026, an estimated $53.4K.
  • Repligen made up ﹤0.01% of Guggenheim Capital's portfolio in Q1 2026, its #1480 holding.
  • Guggenheim Capital first reported a position in Repligen in Q2 2013 and has held it in 45 quarters since.
  • Guggenheim Capital's Repligen position peaked at $11M in Q2 2015.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.